We are happy to announce that the first edition of The Legalcommunity Real Estate Awards 2021 was successfully held at the Four Season Hotel in Milan. For the first time, the community of lawyers active in
Bachem Holding, an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, has raised CHF 583.5 million through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per
BNP Paribas (Suisse) has completed the sale and lease-back of its property located on Place de Hollande in Geneva. The transaction, with a value of approximately CHF 270 million, was signed and closed on October 14/15, 2021. Lenz &
AFFiRiS biotechnology company has entered into a definitive agreement with AC Immune in regards to the sale of its entire portfolio of anti-alpha-synclein immunotherapies in exchange for shares in AC Immune with regard to all
Asml Holding has agreed to sell a 100% stake in BG Medical Applications, SwissOptic and SwissOptic Co., to Jenoptik. BG Medical Applications is a supplier of high-precision, custom optical components for the medical technology sector based
Labster, a platform for virtual labs and interactive science, has signed a definitive agreement to acquire UbiSim, the virtual reality training platform for nursing, based in Lausanne. Labster focuses on early nursing education, offering simulations
myDropz has closed a series seed financing round of approximately CHF 2.5 million additional funding. The round was led by Oyster Bay Venture Capital, a venture capital firm with a focus on healthy, sustainable and functional
Authena, a Zug-based startup which provides a blockchain-based technology to fight product counterfeiting and the lack of transparency in supply chains, has completed a seed financing of over CHF 2.3 million from angel investors from Switzerland
The Bank Council of Basler Kantonalbank (BKB) has appointed Raphael Helbling (pictured) as the new head of legal & compliance and a member of the executive and group management. He is the successor to Regula
CombiGene and Spark Therapeutics, a member of the Roche Group and a fully integrated, commercial gene therapy company dedicated to the fight against genetic diseases, have entered into an exclusive collaboration and licensing agreement for
